78 related articles for article (PubMed ID: 8808807)
1. [Risk factor, natural history and prognosis of the patients with arteriosclerosis obliterans].
Ito M; Mishima Y
Nihon Geka Gakkai Zasshi; 1996 Jul; 97(7):476-80. PubMed ID: 8808807
[TBL] [Abstract][Full Text] [Related]
2. Atherosclerosis obliterans of the lower extremities in Thai patients.
Mutirangura P; Ruangsetakit C; Wongwanit C; Sermsathanasawadi N; Chinsakchai K
J Med Assoc Thai; 2006 Oct; 89(10):1612-20. PubMed ID: 17128835
[TBL] [Abstract][Full Text] [Related]
3. [Medical treatment of arteriosclerosis obliterans (ASO)].
Matsuo H
Nihon Geka Gakkai Zasshi; 1996 Jul; 97(7):520-5. PubMed ID: 8808815
[TBL] [Abstract][Full Text] [Related]
4. [Pathophysiology and diagnosis for arteriosclerosis obliterans].
Sasaki H; Konisi K
Rinsho Byori; 2002 Aug; 50(8):802-6. PubMed ID: 12373817
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of risk factors in patients with peripheral arterial disease. A clinical and epidemiological evaluation.
Novo S; Avellone G; Di Garbo V; Abrignani MG; Liquori M; Panno AV; Strano A
Int Angiol; 1992; 11(3):218-29. PubMed ID: 1460357
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and biochemical parameters of patients with vascular stenosis in the lower extremities in the stage of intermittent claudication].
Kozlovszky B; Mohácsi A; Bajnok L; Csiba L; Országh I; Fülöp T
Orv Hetil; 1995 Apr; 136(16):817-22. PubMed ID: 7644187
[TBL] [Abstract][Full Text] [Related]
7. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
[TBL] [Abstract][Full Text] [Related]
8. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus.
Nojima J; Masuda Y; Iwatani Y; Kuratsune H; Watanabe Y; Suehisa E; Takano T; Hidaka Y; Kanakura Y
Rheumatology (Oxford); 2008 May; 47(5):684-9. PubMed ID: 18375400
[TBL] [Abstract][Full Text] [Related]
9. [Risk factor distribution according to the obesity degree in patients with coronary artery disease].
Sönmez K; Akçakoyun M; Demir D; Akçay A; Pala S; Duran NE; Bakal RB; Gençbay M; Değertekin M; Turan F
Anadolu Kardiyol Derg; 2002 Sep; 2(3):203-10. PubMed ID: 12223326
[TBL] [Abstract][Full Text] [Related]
10. [Why are cardiologists to be concerned about obliterating arterial disease of the lower leg?].
Fisicaro M
Ital Heart J Suppl; 2003 Apr; 4(4):306-18. PubMed ID: 12784766
[TBL] [Abstract][Full Text] [Related]
11. [Distribution of lipoprotein fractions in men with arteriosclerosis obliterans].
Karádi I; Szabolcs Z; Szénási P; Hosszúfalusi N; Császár A; Kusztos R; Romics L
Orv Hetil; 1989 Jul; 130(28):1489-92. PubMed ID: 2748165
[TBL] [Abstract][Full Text] [Related]
12. Classical risk factors and emerging elements in the risk profile for coronary artery disease.
Gensini GF; Comeglio M; Colella A
Eur Heart J; 1998 Feb; 19 Suppl A():A53-61. PubMed ID: 9519344
[TBL] [Abstract][Full Text] [Related]
13. [Secondary prevention of arteriosclerosis].
Hoffmann U; Leu AJ
Praxis (Bern 1994); 1996 Sep; 85(39):1201-5. PubMed ID: 8927904
[TBL] [Abstract][Full Text] [Related]
14. [Cardiovascular risk factors and prevention in women: similarities and differences].
Sclavo M
Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
[TBL] [Abstract][Full Text] [Related]
16. Dilation and reduced distensibility of carotid artery in patients with abdominal aortic aneurysms.
Makita S; Ohira A; Tachieda R; Itoh S; Moriai Y; Niinuma H; Nakamura M; Hiramori K
Am Heart J; 2000 Aug; 140(2):297-302. PubMed ID: 10925346
[TBL] [Abstract][Full Text] [Related]
17. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
18. [Quality of life in patients with risk factors of coronary heart disease].
Kwaśniewska M; Drygas W
Przegl Lek; 2005; 62(9):863-70. PubMed ID: 16541719
[TBL] [Abstract][Full Text] [Related]
19. [The best of epidemiology and cardiovascular prevention in 2006].
Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
[TBL] [Abstract][Full Text] [Related]
20. [Arteriosclerosis obliterans (ASO)].
Koshikawa M; Ikeda U
Nihon Rinsho; 2010 May; 68(5):926-9. PubMed ID: 20446594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
